HIV risks associated with incarceration among injection drug users: Implications for prison-based public health strategies

Journal of Public Health

Volumn 30, Issue 2, 2008, Pages 126-132

  Werb, Daniel ^a   Kerr, Thomas ^a,b   Small, Will ^a   Li, Kathy ^a   Montaner, Julio ^a,b   Wood, Evan ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Drug policy; HIV; IDU; Incarceration; Prison; Syringe sharing

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CANADA; COCAINE DEPENDENCE; CONDOM; DISEASE TRANSMISSION; DRUG ABUSE; FEMALE; HEROIN DEPENDENCE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRISONER; PROSPECTIVE STUDY; SEXUAL BEHAVIOR; SUBSTANCE ABUSE; UTILIZATION REVIEW; VIROLOGY;

ADULT; ANALYSIS OF VARIANCE; BRITISH COLUMBIA; COCAINE-RELATED DISORDERS; CONDOMS; FEMALE; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; MALE; NEEDLE SHARING; PRISONERS; PROSPECTIVE STUDIES; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 44649191715     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdn021     Document Type: Article

References (50)

1. Buavirat A, Page-Shafer K, van Griensven GJ et al. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ 2003;326(7384):308.
2. Dolan KA, Wodak A. HIV transmission in a prison system in an Australian state. Med J Aust 1999;171(1):14-7.
3. Crofts N, Stewart T, Hearne P et al. Spread of bloodborne viruses among Australian prison entrants. BMJ 1995;310(6975):285-8.
4. Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC, endorsed by the Advisory Council for the Elimination of Tuberculosis, the National Commission on Correctional Health Care, and the American Correctional Association. MMWR Recomm Rep 2006;55(RR-9):1-44.
5. Centers for Disease Control and Prevention. Tuberculosis outbreaks in prison housing units for HIV-infected inmates - California, 1995-1996. MMWR Morb Mortal Wkly Rep 1999;48(4):79-82.
6. Centers for Disease Control and Prevention. HIV transmission among male inmates in a state prison system - Georgia, 1992-2005. MMWR Morb Mortal Wkly Rep 2006;55(15):421-26.
7. Gibbons JJ, Katzenbach NB. A report of the commission on safety and abuse in America's prisons. Washington, D.C.: Vera Institute of Justice, 2006.
8. Correctional Services of Canada. Infectious Disease Prevention and Control in Canadian Federal Penitentiaries 2000-01. Ottawa: Correctional Services Canada, 2003.
9. Flanigan TP, Rich JD, Spaulding A. HIV care among incarcerated persons: a missed opportunity. AIDS 1999;13(17):2475.
10. Martin RE, Gold F, Murphy W et al. Drug use and risk of blood-borne infections: a survey of female prisoners in British Columbia. Can J Public Health 2005;96(2):97-101.
11. Jurgens R, Kerr T, Lines R et al. Prison Needle Exchange: Lessons from a Comprehensive Review of International Evidence and Expertise. Toronto: Canadian HIV/AIDS Legal Network, 2006.
12. Correctional investigator. Correctional Inverstigator's Analysis of CSC Action Plan in Response to the Report of the Canadian Human Rights Commission. Ottawa: Correctional Investigator Canada, 2005.
13. Okie S. Sex, drugs, prisons, and HIV. N Engl J Med 2007;356(2):105-8.
14. Spaulding A, Stephenson B, Macalino G et al. Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis 2002;35(3):305-12.
15. Freudenberg N. Jails, prisons, and the health of urban populations: a review of the impact of the correctional system on community health. J Urban Health 2001;78(2):214-35.
16. Dufour A, Alary M, Poulin C et al. Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. AIDS 1996;10(9):1009-15.
17. Hankins CA, Gendron S, Handley MA et al. HIV infection among women in prison: an assessment of risk factors using a nonnominal methodology. Am J Public Health 1994;84(10):1637-40.
18. Walmsley R. World Prison Population List. London: International Centre for Prison Studies, 2003.
19. Sarang A, Rhodes T, Platt L et al. Drug injecting and syringe use in the HIV risk environment of Russian penitentiary institutions: qualitative study. Addiction 2006;101(12):1787-96.
20. Tyndall MW, Currie S, Spittal P et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 2003;17(6):887-93.
21. Kaiser Network. California Gov. Schwarzenegger vetoes prison condom distribution bill. Kaiser Network. 2006-10-02.
22. Department of Justice. Conditional Sentencing Reform Bill (Backgrounder). Ottawa: Department of Justice, 2006.
23. Kerr T, Palepu A, Barness G et al. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver. Antivir Ther 2004;9(3):407-14.
24. Liang KY, Zeger SL. Longitudinal data using generalized linear models. Biometrika 1986;73:13-22.
25. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42(1):121-30.
26. Lipsitz SR, Molenberghs G, Fitzmaurice GM et al. GEE with Gaussian estimation of the correlations when data are incomplete. Biometrics 2000;56:528-36.
27. Wood E, Tyndall MW, Spittal PM et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help? CMAJ 2001;165(4):405-10.
28. Lines R. Action on HIV/AIDS in prisons: too little, too late - a report card. Montreal: Canadian HIV/AIDS Legal Network, 2002.
29. Polonsky S, Kerr S, Harris B et al. HIV prevention in prisons and jails: obstacles and opportunities. Public Health Rep 1994;109(5): 615-25.
30. UNAIDS. Prisons and AIDS: UNAIDS Point of View. Geneva: UNAIDS Information Centre, 1997.
31. WHO. Status Paper on Prisons, Drugs and Harm Reduction. Copenhagen: World Health Organization, 2005.
32. Kim S, Coletti SD. Benefit-cost analysis of drug abuse prevention programs: a macroscopic approach. J Drug Educ 1995;25(2):111.
33. Rehm J, Gschwend P, Steffen T et al. Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet 2001;358(9291):1417-23.
34. Schackman BR, Gebo KA, Walensky RP et al. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 2006;44(11):990.
35. Levy AR, James D, Johnston KM et al. The direct costs of HIV/AIDS care. Lancet Infect Dis 2006;6(3):171-7.
36. Albert T, Williams G, Remis R et al. Canadian Policy Research Network: The Economic Burden of HIV/AIDS in Canada. Ottawa: Renouf Publishing Co. Ltd., 1998.
37. Correctional Service Canada. HIV/AIDS in prisons: Final Report of the Expert Committee on AIDS and Prisons. Ottawa: Minister of Supply and Services, 1994.
38. Ehrmann T. Community-based organizations and HIV prevention for incarcerated populations: three HIV prevention program models. AIDS Educ Prev 2002;14(5 Suppl B):75-84.
39. Clarke JG, Stein MD, Hanna L et al. Active and former injection drug users report of HIV risk behaviors during periods of incarceration. Subst Abus 2001;22(4):209-16.
40. Centers for Disease Control and Prevention. HIV/AIDS education and prevention programs for adults in prisons and jails and juveniles in confinement facilities - United States, 1994. 1996. Report No 45.
41. Small W, Kain S, Laliberte N et al. Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison. Subst Use Misuse 2005;40(6):831-43.
42. CBC. Prison tattoo parlours get the axe. CBC. 2006. Available at http://www.cbc.ca/canada/story/2006/12/04/tattoo-program.html (17 December 2006, date last accessed).
43. Dolan K, Rutter S, Wodak AD. Prison-based syringe exchange programmes: a review of international research and development. Addiction 2003;98(2):153-8.
44. World Health Organization. WHO guidelines on HIV infection and AIDS in prisons. Geneva: WHO, 1993. Report No (WHO/GPA/DIR/93.3).
45. Guardian. UK prisoner takes legal action on lack of needle exchange. Guardian. 2005.
46. Yirrell DL, Robertson P, Goldberg DJ et al. Molecular investigation into outbreak of HIV in a Scottish prison. BMJ 1997;314(7092):1446-50.
47. Des Jarlais DC, Paone D, Milliken J et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet 1999;353(9165):1657-61.
48. O'Callaghan F, Sonderegger N, Klag S. Drug and crime cycle: evaluating traditional methods versus diversion strategies for drug-related offences. Aus Psych 2004;39(3):188.
49. Broner N, Mayrl DW, Landsberg G. Outcomes of mandated and nonmandated New York City jail diversion for offenders with alcohol, drug and mental disorders. Prison J 2005;85(1):18.
50. Zaric GS, Barnett PG, Brandeau ML. HIV transmission and the cost-effectiveness of methadone maintenance. Am J Pub Health 2000;90(7):1100-11.